Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vabysmo
Pharma
FDA gives thumbs-up to Roche's Susvimo as treatment for DME
The FDA has broadened the label of Roche's eye implant Susvimo to treat diabetic macular edema, the leading cause of diabetes-related blindness.
Kevin Dunleavy
Feb 4, 2025 3:15pm
UK watchdog reaffirms Bayer's claims of misleading Roche promos
Jan 31, 2025 11:20am
Roche's Vabysmo crosses $4B mark as Polivy joins blockbuster club
Jan 30, 2025 11:06am
JPM25: Regeneron has few answers for declining sales of Eylea HD
Jan 14, 2025 10:25am
Asian patients with PCV show improvement with Roche's Vabysmo
Nov 22, 2024 7:00am
Eylea HD sales jump in Q3 but Regeneron still cedes market share
Oct 31, 2024 11:37am